• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于稳定生产重组蛋白和工程抗体的附加型载体。

Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies.

作者信息

Fallahee Ian, Hawiger Daniel

机构信息

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.

出版信息

Antibodies (Basel). 2024 Mar 11;13(1):18. doi: 10.3390/antib13010018.

DOI:10.3390/antib13010018
PMID:38534208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967652/
Abstract

There is tremendous interest in the production of recombinant proteins, particularly bispecific antibodies and antibody-drug conjugates for research and therapeutic use. Here, we demonstrate a highly versatile plasmid system that allows the rapid generation of stable Expi293 cell pools by episomal retention of transfected DNA. By linking protein expression to puromycin resistance through an attenuated internal ribosome entry site, we achieve stable cell pools producing proteins of interest. In addition, split intein-split puromycin-mediated selection of two separate protein expression cassettes allows the stable production of bispecific antibody-like molecules or antibodies with distinct C-terminal heavy chain modifications, such as an antigen on one chain and a sortase tag on the other chain. We also use this novel expression system to generate stable Expi293 cell pools that secrete sortase A Δ59 variant Srt4M. Using these reagents, we prepared a site-specific drug-to-antibody ratio of 1 antibody-siRNA conjugate. We anticipate the simple, robust, and rapid stable protein expression systems described here being useful for a wide variety of applications.

摘要

人们对重组蛋白的生产,尤其是用于研究和治疗的双特异性抗体及抗体药物偶联物有着浓厚的兴趣。在此,我们展示了一种高度通用的质粒系统,该系统通过转染DNA的游离保留实现了稳定的Expi293细胞池的快速生成。通过一个弱化的内部核糖体进入位点将蛋白质表达与嘌呤霉素抗性联系起来,我们获得了产生感兴趣蛋白质的稳定细胞池。此外,分裂内含肽-分裂嘌呤霉素介导的两个独立蛋白质表达盒的选择,使得能够稳定生产双特异性抗体样分子或具有不同C末端重链修饰的抗体,例如一条链上带有抗原而另一条链上带有分选酶标签。我们还使用这个新型表达系统生成了分泌分选酶A Δ59变体Srt4M的稳定Expi293细胞池。利用这些试剂,我们制备了位点特异性药物与抗体比例为1的抗体-siRNA偶联物。我们预计本文所述的简单、稳健且快速的稳定蛋白质表达系统将适用于多种应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/e62817b797c0/antibodies-13-00018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/4784e36b835a/antibodies-13-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/29f8995684a4/antibodies-13-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/a18ce4e7374c/antibodies-13-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/79e2af05c7c9/antibodies-13-00018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/e62817b797c0/antibodies-13-00018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/4784e36b835a/antibodies-13-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/29f8995684a4/antibodies-13-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/a18ce4e7374c/antibodies-13-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/79e2af05c7c9/antibodies-13-00018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3085/10967652/e62817b797c0/antibodies-13-00018-g005.jpg

相似文献

1
Episomal Vectors for Stable Production of Recombinant Proteins and Engineered Antibodies.用于稳定生产重组蛋白和工程抗体的附加型载体。
Antibodies (Basel). 2024 Mar 11;13(1):18. doi: 10.3390/antib13010018.
2
EPISOMAL VECTORS FOR STABLE PRODUCTION OF RECOMBINANT PROTEINS AND ENGINEERED ANTIBODIES.用于稳定生产重组蛋白和工程抗体的附加型载体
bioRxiv. 2024 Jan 4:2024.01.03.574076. doi: 10.1101/2024.01.03.574076.
3
The eIg technology to generate Ig-like bispecific antibodies.利用 eIg 技术生成 Ig 样双特异性抗体。
MAbs. 2022 Jan-Dec;14(1):2063043. doi: 10.1080/19420862.2022.2063043.
4
Full-length recombinant antibodies from : production, characterization, effector function (Fc) engineering, and clinical evaluation.全长重组抗体:生产、表征、效应功能(Fc)工程和临床评估。
MAbs. 2022 Jan-Dec;14(1):2111748. doi: 10.1080/19420862.2022.2111748.
5
Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.来自COS细胞瞬时表达系统的具有新型生物学特性和抗肿瘤活性的单链单特异性和双特异性抗体衍生物。
Ther Immunol. 1994 Jan;1(1):3-15.
6
Naturally split intein Npu DnaE mediated rapid generation of bispecific IgG antibodies.天然分裂内含肽 Npu DnaE 介导的双特异性 IgG 抗体的快速产生。
Methods. 2019 Feb 1;154:32-37. doi: 10.1016/j.ymeth.2018.10.001. Epub 2018 Oct 9.
7
Sortase A Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody-Drug Conjugates.分选酶A酶介导的位点特异性偶联抗体-药物偶联物的生成。
Methods Mol Biol. 2019;2012:1-13. doi: 10.1007/978-1-4939-9546-2_1.
8
Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis.通过 CDR 突变理性设计和生成重组双特异性抗体对照试剂。
J Immunol Methods. 2013 Sep 30;395(1-2):14-20. doi: 10.1016/j.jim.2013.06.003. Epub 2013 Jun 24.
9
Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools.通过猪尾巴(PiggyBac)转座子介导的稳定中国仓鼠卵巢(CHO)细胞池快速生产重组蛋白。
J Biotechnol. 2015 Apr 20;200:61-9. doi: 10.1016/j.jbiotec.2015.03.001. Epub 2015 Mar 7.
10
"BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.“双特异性抗体”:在瞬时转染的哺乳动物细胞中生产IgG形式的双特异性抗体
Methods Mol Biol. 2019;1904:431-454. doi: 10.1007/978-1-4939-8958-4_22.

引用本文的文献

1
Construction of an Integration Vector with a Chimeric Signal Peptide for the Expression of Monoclonal Antibodies in Mammalian Cells.用于在哺乳动物细胞中表达单克隆抗体的带有嵌合信号肽的整合载体的构建
Curr Issues Mol Biol. 2024 Dec 22;46(12):14464-14475. doi: 10.3390/cimb46120868.

本文引用的文献

1
Fc-Engineered Therapeutic Antibodies: Recent Advances and Future Directions.Fc工程化治疗性抗体:最新进展与未来方向
Pharmaceutics. 2023 Sep 28;15(10):2402. doi: 10.3390/pharmaceutics15102402.
2
Protein-Specific Signal Peptides for Mammalian Vector Engineering.蛋白质特异性信号肽用于哺乳动物载体工程。
ACS Synth Biol. 2023 Aug 18;12(8):2339-2352. doi: 10.1021/acssynbio.3c00157. Epub 2023 Jul 24.
3
Protein production from HEK293 cell line-derived stable pools with high protein quality and quantity to support discovery research.
从 HEK293 细胞系衍生的稳定池高效生产蛋白质,以保证高质量和高数量的蛋白质,从而支持发现研究。
PLoS One. 2023 Jun 2;18(6):e0285971. doi: 10.1371/journal.pone.0285971. eCollection 2023.
4
Consensus design and engineering of an efficient and high-yield peptide asparaginyl ligase for protein cyclization and ligation.高效高产肽天冬酰胺连接酶的共识设计和工程化用于蛋白质环化和连接。
J Biol Chem. 2023 Mar;299(3):102997. doi: 10.1016/j.jbc.2023.102997. Epub 2023 Feb 9.
5
Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?RNA 治疗药物的内体逃逸:我们如何解决这个限速问题?
RNA. 2023 Apr;29(4):396-401. doi: 10.1261/rna.079507.122. Epub 2023 Jan 20.
6
O-glycosylation and its role in therapeutic proteins.O-糖基化及其在治疗性蛋白质中的作用。
Biosci Rep. 2022 Oct 28;42(10). doi: 10.1042/BSR20220094.
7
Production of Eukaryotic Glycoproteins for Structural and Functional Studies Using Expi293F Cells.使用 Expi293F 细胞生产用于结构和功能研究的真核糖蛋白。
Curr Protoc. 2022 Aug;2(8):e512. doi: 10.1002/cpz1.512.
8
TNF-α sculpts a maturation process in vivo by pruning tolerogenic dendritic cells.TNF-α 通过修剪耐受性树突状细胞来塑造体内的成熟过程。
Cell Rep. 2022 Apr 12;39(2):110657. doi: 10.1016/j.celrep.2022.110657.
9
Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo.体内靶向树突状细胞的基于抗体的抗原递送应用
Antibodies (Basel). 2022 Jan 25;11(1):8. doi: 10.3390/antib11010008.
10
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors.HEK293细胞系作为生产重组蛋白和病毒载体的平台。
Front Bioeng Biotechnol. 2021 Dec 13;9:796991. doi: 10.3389/fbioe.2021.796991. eCollection 2021.